Altered Substrate Specificity of Drug-Resistant Human Immunodeficiency Virus Type 1 Protease

Resistance to human immunodeficiency virus type 1 protease (HIV PR) inhibitors results primarily from the selection of multiple mutations in the protease region. Because many of these mutations are selected for the ability to decrease inhibitor binding in the active site, they also affect substrate...

Полное описание

Библиографические подробности

Опубликовано в::	J Virol
Главные авторы:	Dauber, Deborah S., Ziermann, Rainer, Parkin, Neil, Maly, Dustin J., Mahrus, Sami, Harris, Jennifer L., Ellman, Jon A., Petropoulos, Christos, Craik, Charles S.
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 2002
Предметы:	Vaccines and Antiviral Agents
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC135855/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11773410/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.76.3.1359-1368.2002
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!